Reporting of clinical trial number on claims will be mandatory. Therefore, this information will now be requested on the Enrollment
Effective January 1, 2014, The Centers for Medicare & Medicaid Services (CMS) will require
inclusion of an 8-digit clinical trial number on claims associated with clinical trial participation.
Clinical trial related claims submitted to Medicare for dates of services on or after January 1, 2014,
will be returned to the provider if the 8-digit clinical trial number is not present.
The 8-digit clinical trial number, also called the National Clinical Trial (NCT) Number or Clinical
Trials Identifier, can be found on the ClinicalTrials.gov website. The sponsor of the clinical trial,
which can include the principal investigator, is responsible for registering the clinical trial with
ClinicalTrials.gov within 21 days of enrollment of the first participant. The 8-digit clinical trial
number is assigned and released 2-5 business days after the clinical trial information has been
submitted. This 8-digit clinical trial number will be added to the list of other required data:
Revised enrollment forms and updated encounter Forms are now on the website and should be
utilized effective immediately. Please discard all older versions as you will be asked to re-submit
using the new forms only.
J14 A/B MACNHIC, Corp. - J14 MAC - Special Part A / Part B MessageSeptember 23, 2013
NHIC, Corp. currently reviews investigational device exemption (IDE) clinical study requests from both hospitals and
physicians in the New England (J14) region which includes the states of MA, ME, NH, VT, and RI. Providers participating in
an IDE clinical study and who anticipate filing Medicare claims must notify their Medicare contractor in advance. This
Notice is not required for humanitarian use devices, post-market approval studies or registries of devices other than
carotid stents, or clinical studies other than those described above. IDE request determinations (approval or denial) are
retroactive to the date the documentation to complete the request is received by NHIC, Corp. or the effective date of the
Institutional Review Board (IRB) approval, whichever is later.
National Government Services (NGS) is the contractor for the new Jurisdiction K A/B Medicare Administrative Contractor
(MAC) and will assume responsibility for the New England region (MA, ME, NH, VT, and RI) on October 18, 2013 for Part A and
on October 25, 2013 for Part B. NHIC, Corp. will provide NGS with an updated list of all previously approved/denied IDE
requests for both Part A and Part B providers. Both Part A and Part B provider IDE clinical study requests will not be
processed by NHIC, Corp. after October 04, 2013. Any current requests which are in process will be finalized if all
documentation is received by October 3, 2013. Otherwise, MA, ME, NH, VT, and RI providers will have to reapply to National
Government Services (NGS). All new or renewal IDE clinical study requests submitted after October 4, 2013 from facilities
and providers in MA, ME, NH, VT and RI shall be emailed to:
Email is preferred, but you can also fax requests to: (717) 565-3432 or mail request to:National Government Services, Inc.Medical Policy UnitATTN: Lauri Sersch, CPC - IDE RequestP.O. Box 7108Indianapolis, IN 46207-7108
Did you know that effective January 1, 2012 a COVERAGE ANALYSIS (CA) needs to be created by you and submitted to the Research Billing Compliance Manger, Deb Temple for all new studies meeting the following requirements?
Required for any research study that interacts with subjects when that interaction could generate a charge such as a clinic visit, lab draw, EKG, x-ray, CT, MRI, etc…Under the current Medicare rules, there is no way around reviewing the details of each research study in order to find out what is billable to Medicare and what is not!
Kelly Willenberg, an outside consultant, held training sessions on how to complete the COVERAGE ANALYSIS early in October 2011 and we have posted the sessions on the Research Administration website for reference, but for anyone who would like more in-depth instruction, Deb Temple will be holding training sessions on Thursday mornings, from 8-9:30 in the Aldrich 5 conference room.
Bring your study information (protocol including a schedule of events, external budget, draft informed consent, etc...) and she will take you through the process. The CA TEMPLATE we will be using can be located on our website along with the QUALIFYING CLINICAL TRIAL (QCT) DETERMINATION FORM.